☆ 4.6 Article

The Interplay among Glucocorticoid Therapy, Platelet-Activating Factor and Endocannabinoid Release Influences the Inflammatory Response to COVID-19

VIRUSES-BASEL (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Medicine, General & Internal

Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence

Riccardo Sarzani et al.

Summary: The use of glucocorticoid drugs like dexamethasone for severe COVID-19 patients, especially those requiring mechanical ventilation or supplemental oxygen therapy, has shown the largest benefit. However, there may be no benefit for patients without hypoxemia. Administering dexamethasone after several days of symptoms can lead to positive outcomes, but early administration may have potential harm, with the optimum time for glucocorticoid administration still being debated.

INTERNAL AND EMERGENCY MEDICINE (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: A systematic review and meta-analysis of randomised trials

Elisabetta Caiazzo et al.

Summary: This study investigated the effect of systemic administration of glucocorticoids on cardiovascular complications and all-cause mortality in patients hospitalized with respiratory viral infections, including COVID-19. The results showed that glucocorticoids did not lower overall mortality in hospitalized patients, but may reduce mortality in those requiring respiratory support and increase it in those who do not.

PHARMACOLOGICAL RESEARCH (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Dual inhibition of CB1 receptors and iNOS, as a potential novel approach to the pharmacological management of acute and long COVID-19

Resat Cinar et al.

Summary: COVID-19 causes multiple inflammatory complications, therapeutic targets are needed for managing acute cases and preventing long-term effects, potentially through targeting pathologic changes induced via multiple pathways and using a polypharmacology approach.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?

Wei Shen Ho et al.

Summary: This review analyzes the merits and limitations of drugs tested against SARS-CoV-2 and used for adjuvant therapy. Although many of these drugs have been proven ineffective, important lessons can be learned. The recent inclusion of molnupiravir and PaxlovidTM as treatment options for COVID-19 represents our best hope to date for living with COVID-19.

PHARMACOLOGICAL RESEARCH (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection

Claudio G. Gallo et al.

PROSTAGLANDINS & OTHER LIPID MEDIATORS (2022)

添加到收藏夹

Article Infectious Diseases

A Retrospective Study of Dexamethasone, Remdesivir, and Baricitinib in Severe COVID-19

Dallis Q. Ngo et al.

Summary: This study found that triple therapy with dexamethasone, remdesivir, and baricitinib was associated with a significant survival benefit compared to dual therapy with dexamethasone and remdesivir in patients with severe COVID-19 requiring HFNC. However, there was no significant difference in the requirement of mechanical ventilation, length of stay, and days on HFNC between the two groups.

CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY (2022)

添加到收藏夹

Article Virology

Combination therapy with remdesivir and immunomodulators improves respiratory status in COVID-19: A retrospective study

Yuichi Kojima et al.

Summary: Combination therapy with immunomodulators and remdesivir can improve respiratory status of COVID-19 patients, leading to faster recovery and improvement in severity level.

JOURNAL OF MEDICAL VIROLOGY (2022)

添加到收藏夹

Editorial Material Chemistry, Medicinal

CB2 receptor-selective agonists as candidates for targeting infection, inflammation, and immunity in SARS-CoV-2 infections

M. F. Nagoor Meeran et al.

Summary: The COVID-19 pandemic caused by SARS-CoV-2 continues to affect millions due to lack of drugs and vaccines. Therapeutic strategies involving activation of cannabinoid type-2 receptors (CB2R) have shown potential in suppressing hyperimmune-inflammatory responses, providing a promising avenue for further investigation and potential treatment against the virus.

DRUG DEVELOPMENT RESEARCH (2021)

添加到收藏夹

Editorial Material Multidisciplinary Sciences

Bioactive lipids in antiviral immunity

Katherine N. Theken et al.

SCIENCE (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

In quest of a new therapeutic approach in COVID-19: the endocannabinoid system

Ondine Lucaciu et al.

Summary: Despite the potential benefits of the cannabinoid system in the treatment of SARS-CoV-2 infected patients, further research is needed to better understand its impact in this situation. The activation of the endocannabinoid system can lead to various beneficial effects, such as reducing viral entry and replication, decreasing pro-inflammatory cytokines, and increasing anti-inflammatory cytokines.

DRUG METABOLISM REVIEWS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Dissecting lipid metabolism alterations in SARS-CoV-2

Ilaria Casari et al.

Summary: Lipid metabolism plays a crucial role in the pathogenesis of the novel coronavirus, with circulating lipids directly correlating to disease severity. Metabolomic and lipidomic approaches provide new insights into potential therapeutic targets for COVID-19.

PROGRESS IN LIPID RESEARCH (2021)

添加到收藏夹

Article Virology

sTREM-1 Predicts Disease Severity and Mortality in COVID-19 Patients: Involvement of Peripheral Blood Leukocytes and MMP-8 Activity

Pedro V. da Silva-Neto et al.

Summary: This study investigated the role of soluble TREM-1 as a biomarker in COVID-19 severity and mortality, finding a significant correlation with disease severity, inflammatory parameters, and negative correlation with lymphocyte counts. The study suggests sTREM-1 could be a predictive tool for disease outcome in COVID-19 patients.

VIRUSES-BASEL (2021)

添加到收藏夹

Review Immunology

Complement cascade in severe forms of COVID-19: Recent advances in therapy

Nassima Chouaki Benmansour et al.

Summary: The overactivation of the complement system in severe cases of COVID-19 can lead to serious complications, and immunotherapies show promise in the treatment of the disease. Complement blockade, particularly targeting the C5a-C5aR axis, may help prevent the worsening of ARDS.

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

添加到收藏夹

Article Cell Biology

Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis

Muthanna Sultan et al.

Summary: The study showed that treatment with anandamide (AEA) attenuated SEB-mediated ARDS by inducing AMPs, tight junction proteins, and short-chain fatty acids (SCFAs), which stabilized the gut-lung microbial axis, suppressed inflammation, and prevented dysbiosis in both the lungs and the gut.

CELLS (2021)

添加到收藏夹

Article Medicine, Research & Experimental

The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial

Saeid Doaei et al.

Summary: This study investigated the effects of n3-PUFA supplementation on critically ill patients with COVID-19. The results suggest that Omega-3 supplementation can improve certain biochemical and inflammatory markers, as well as increase survival rates in critically ill patients.

JOURNAL OF TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

The Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome by Downregulating miRNA that Target Inflammatory Pathways

Muthanna Sultan et al.

Summary: This study demonstrates that endocannabinoids like AEA can alleviate ARDS induced by SEB by suppressing inflammation through down-regulation of key miRNA that regulate immunosuppressive pathways. Treatment with AEA in mice showed improvements in lung function, reduced inflammatory cell infiltrate, and modulation of pro-inflammatory cytokines and immune cells in the lungs. Additionally, AEA altered miRNA expression, leading to the induction of anti-inflammatory phenotypes and the regulation of immunosuppressive pathways.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Review Physiology

The Role of Innate Immunity and Bioactive Lipid Mediators in COVID-19 and Influenza

Sabina Sahanic et al.

Summary: This review focuses on the spatiotemporal kinetics and inflammatory signatures of innate immune cells in response to SARS-CoV-2 compared to influenza virus infection, highlighting the mechanisms underlying exaggerated inflammation and death. Insights from investigating a public RNA-seq database of bronchoalveolar lavage cells from COVID-19 patients offer critical information on the regulation of key enzymes involved in lipid mediator synthesis, contributing to the current understanding of the lipidome in severe cases. Additionally, potential approaches to sustain the synthesis of pro-resolving lipid mediators derived from 3-PUFAs are discussed as crucial in preventing acute lung injury and fatality from COVID-19.

FRONTIERS IN PHYSIOLOGY (2021)

添加到收藏夹

Review Microbiology

Lipid droplets and lipid mediators in viral infection and immunity

Ebony A. Monson et al.

Summary: Lipid droplets play crucial roles in cellular physiology and pathophysiology, regulating lipid storage, protein sequestration, and serving as hubs for integrating metabolic and inflammatory processes in response to cellular stress.

FEMS MICROBIOLOGY REVIEWS (2021)

添加到收藏夹

Review Medicine, General & Internal

Ivermectin for preventing and treating COVID-19

Maria Popp et al.

Summary: The current evidence regarding the efficacy and safety of ivermectin for treating or preventing COVID-19 is very low to low-certainty, with most completed studies being small and of low quality. Ongoing studies may provide more definitive answers. Overall, reliable evidence does not support the use of ivermectin for COVID-19 treatment or prevention without well-designed randomized trials.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)

添加到收藏夹

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

添加到收藏夹

Article Medicine, General & Internal

Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)

Pei-Fang Wei

CHINESE MEDICAL JOURNAL (2020)

添加到收藏夹

Review Rheumatology

Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment

Mehmet Soy et al.

CLINICAL RHEUMATOLOGY (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Clinical and immunological features of severe and moderate coronavirus disease 2019

Guang Chen et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

添加到收藏夹

Article Virology

Clinical features and treatment of COVID-19 patients in northeast Chongqing

Suxin Wan et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

Chaomin Wu et al.

JAMA INTERNAL MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou et al.

LANCET (2020)

添加到收藏夹

Review Medicine, General & Internal

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review

W. Joost Wiersinga et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Coronavirus 2019, Microthromboses, and Platelet Activating Factor

Theoharis C. Theoharides et al.

CLINICAL THERAPEUTICS (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Efficacy and safety of current therapeutic options for COVID-19-lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis

Han Zhong et al.

PHARMACOLOGICAL RESEARCH (2020)

添加到收藏夹

Article Medicine, Research & Experimental

The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID-19 Patients: A Retrospective Cohort Study

Chen Shi et al.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)

添加到收藏夹

Article Critical Care Medicine

Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study

Jianfeng Xie et al.

INTENSIVE CARE MEDICINE (2020)

添加到收藏夹

Editorial Material Pharmacology & Pharmacy

Targeting inflammation and cytokine storm in COVID-19

Qianwen Huang et al.

PHARMACOLOGICAL RESEARCH (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

COVID-19, microthromboses, inflammation, and platelet activating factor

Constantinos Demopoulos et al.

BIOFACTORS (2020)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Metabolic Syndrome and COVID-19

Hidekatsu Yanai

CARDIOLOGY RESEARCH (2020)

添加到收藏夹

Article Endocrinology & Metabolism

Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection

Timotius Ivan Hariyanto et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)

添加到收藏夹

Review Medicine, Research & Experimental

SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy

Prasun K. Datta et al.

THERANOSTICS (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Immune Responses Regulated by Cannabidiol

James M. Nichols et al.

CANNABIS AND CANNABINOID RESEARCH (2020)

添加到收藏夹

Article Medicine, General & Internal

Cannabinoid receptor 2: a potential novel therapeutic target for sepsis?

Qianwen He et al.

ACTA CLINICA BELGICA (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives

Ronan Lordan et al.

MOLECULES (2019)

添加到收藏夹

Article Critical Care Medicine

Clinical Pharmacology of Corticosteroids

Dennis M. Williams

RESPIRATORY CARE (2018)

添加到收藏夹

Review Endocrinology & Metabolism

Therapeutic Mechanisms of Glucocorticoids

Jolien Vandewalle et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2018)

添加到收藏夹

Review Immunology

Bioactive Lipids and Chronic Inflammation: Managing the Fire Within

Valerio Chiurchiu et al.

FRONTIERS IN IMMUNOLOGY (2018)

添加到收藏夹

Review Physiology

FROM PHYTOCANNABINOIDS TO CANNABINOID RECEPTORS AND ENDOCANNABINOIDS: PLEIOTROPIC PHYSIOLOGICAL AND PATHOLOGICAL ROLES THROUGH COMPLEX PHARMACOLOGY

Alessia Ligresti et al.

PHYSIOLOGICAL REVIEWS (2016)

添加到收藏夹

Review Immunology

The endocannabinoid system and its therapeutic implications in rheumatoid arthritis

Huan Gui et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2015)

添加到收藏夹

Article Biochemical Research Methods

Rapid and Reliable Identification of Phospholipids for Untargeted Metabolomics with LC-ESI-QTOF-MS/MS

Joanna Godzien et al.

JOURNAL OF PROTEOME RESEARCH (2015)

添加到收藏夹

Review Pharmacology & Pharmacy

Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS

N. Murataeva et al.

BRITISH JOURNAL OF PHARMACOLOGY (2014)

添加到收藏夹

Article Neurosciences

Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity

Gopinath Krishnan et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2014)

添加到收藏夹

Review Chemistry, Medicinal

Platelet-activating factor (PAF)-antagonists of natural origin

Preeti Singh et al.

FITOTERAPIA (2013)

添加到收藏夹

Article Immunology

Mineralocorticoid and glucocorticoid receptors differentially regulate NF-kappaB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells

Boonrat Chantong et al.

JOURNAL OF NEUROINFLAMMATION (2012)

添加到收藏夹

Article Computer Science, Interdisciplinary Applications

qgraph: Network Visualizations of Relationships in Psychometric Data

Sacha Epskamp et al.

JOURNAL OF STATISTICAL SOFTWARE (2012)

添加到收藏夹

Review Neurosciences

Endocannabinoid Signaling and Synaptic Function

Pablo E. Castillo et al.

NEURON (2012)

添加到收藏夹

Review Chemistry, Multidisciplinary

Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling Pathways

Carol A. Rouzer et al.

CHEMICAL REVIEWS (2011)

添加到收藏夹

Article Multidisciplinary Sciences

Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation

Daniel K. Nomura et al.

SCIENCE (2011)

添加到收藏夹

Article Neurosciences

The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors

William R. Marrs et al.

NATURE NEUROSCIENCE (2010)

添加到收藏夹

Article Biochemistry & Molecular Biology

Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation

Guy A. Cabral et al.

EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)

添加到收藏夹

Review Pharmacology & Pharmacy

Endocannabinoids and immune regulation

Rupal Pandey et al.

PHARMACOLOGICAL RESEARCH (2009)

添加到收藏夹

Article Biochemistry & Molecular Biology

Identification of a novel noninflammatory biosynthetic pathway of platelet-activating factor

Takeshi Harayama et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

添加到收藏夹

Article Biochemistry & Molecular Biology

Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-n-acyl ethanolamine precursors in mouse brain

Gabriel M. Simon et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

添加到收藏夹

Review Biochemistry & Molecular Biology

Endocannabinoid signaling as a synaptic circuit breaker in neurological disease

Istvan Katona et al.

NATURE MEDICINE (2008)

添加到收藏夹

Article Neurosciences

Multiple pathways involved in the biosynthesis of anandamide

Jie Liu et al.

NEUROPHARMACOLOGY (2008)

添加到收藏夹

Article Endocrinology & Metabolism

Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease

G. Cabral et al.

Endocrine Metabolic & Immune Disorders-Drug Targets (2008)

添加到收藏夹

Article Biochemistry & Molecular Biology

A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol

Jacqueline L. Blankman et al.

CHEMISTRY & BIOLOGY (2007)

添加到收藏夹

Article Biochemistry & Molecular Biology

Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesis

Jiawei Chen et al.

JOURNAL OF LIPID RESEARCH (2007)

添加到收藏夹

Article Immunology

Dexamethasone suppresses interleukin-1β-induced human β-defensin 2 mRNA expression:: involvement of p38 MAPK, JNK, MKP-1, and NF-κB transcriptional factor in A549 cells

Byeong-Churl Jang et al.

FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2007)

添加到收藏夹

Article Biochemistry & Molecular Biology

A single enzyme catalyzes both platelet-activating factor production and membrane biogenesis of inflammatory cells -: Cloning and characterization of acetyl-CoA:lyso-PAF acetyltransferase

Hideo Shindou et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

添加到收藏夹

Article Biochemistry & Molecular Biology

Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN

Mark Lowenberg et al.

EMBO REPORTS (2006)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Bioconductor: open software development for computational biology and bioinformatics

RC Gentleman et al.

GENOME BIOLOGY (2004)

添加到收藏夹

Article Neurosciences

Platelet-activating factor: a previously unrecognized mediator of fever

AI Ivanov et al.

JOURNAL OF PHYSIOLOGY-LONDON (2003)

添加到收藏夹

Review Multidisciplinary Sciences

Points of control in inflammation

C Nathan

NATURE (2002)

添加到收藏夹

Article Critical Care Medicine

The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis

GA Zimmerman et al.

CRITICAL CARE MEDICINE (2002)

添加到收藏夹

Review Pharmacology & Pharmacy

Molecular mechanisms of immunomodulatory activity of glucocorticoids

C Riccardi et al.

PHARMACOLOGICAL RESEARCH (2002)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Oxidized LDL contains inflammatory PAF-like phospholipids

GK Marathe et al.

TRENDS IN CARDIOVASCULAR MEDICINE (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.